<DOC>
	<DOCNO>NCT01156649</DOCNO>
	<brief_summary>Obstructive sleep apnea problem large number child result problem think pattern , behavior sleep left untreated . Little known positive airway pressure ( PAP ) therapy might help child need treatment obstructive sleep apnea . We investigate PAP therapy might able improve thinking pattern , behavior sleep problem child obstructive sleep apnea .</brief_summary>
	<brief_title>Effects Positive Airway Pressure ( PAP ) Children With Obstructive Sleep Apnea ( OSA )</brief_title>
	<detailed_description>Positive airway pressure ( PAP ) therapy show effective treatment improve neurocognitive performance sleep pattern adult obstructive sleep apnea ( OSA ) . However , effect PAP therapy neurocognitive , behavioral sleep pattern school-aged child OSA well known . The goal innovative study conduct randomize , double-blind , placebo control , trial determine effect PAP therapy neurocognitive behavioral pattern sleep architecture child OSA . A battery neurocognitive test parent behavioral rating assessment give school-aged child OSA , 3 month 6 month treatment PAP therapy ; 3 month PAP placebo use follow 3 month PAP therapy . Full polysomnography PAP titration sleep study perform follow night adaptation sleep sleep laboratory three time point . Compliance PAP therapy monitor daily basis remote internet-linked communicator attach participant 's PAP pressure generator . The hypothesis ground-breaking project 3 month continuous compliance regimen PAP therapy result significant improvement neurocognitive behavioral pattern sleep architecture positively change become reflective normative value school-aged child . The result innovative ground-breaking study far-reaching effect sleep clinician health care provider support continue use PAP therapy treatment OSA inform health-care community efficacy PAP therapy neurocognition behavior pattern school-aged child OSA .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>1 . Age 6.0 11.9 year 2 . Nocturnal PSG ( polysomnography ) show apnea/hypopnea index least 1.510 event average per hour sleep apnea index le 1 per hour ( mild moderate OSA group ) , , PSG show apnea index 1 great PLUS apnea/hypopnea index 10.0 great ( severe OSA group ) . 3 . English spoken child 's primary language . 4 . Willingness complete study protocol randomize placebo treatment group . 1 . The presence diagnosable sleep disorder OSA . 2 . Previous use PAP therapy sleep disorder breathing time patient 's history 3 . Presence health problem likely interfere neurocognitive test result interpretation , previously diagnose psychiatric illness ( i.e. , attentiondeficit hyperactivity disorder , depression , psychosis ) medical genetic syndrome ( i.e. , PraderWilli syndrome , Fragile X ) . 4 . Presence chronic neurological disorder , chronic renal failure , diabetes , rheumatoid arthritis , another chronic inflammatory condition .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Obstructive sleep apnea</keyword>
	<keyword>neurocognitive function</keyword>
	<keyword>cognition</keyword>
	<keyword>pediatrics</keyword>
	<keyword>child</keyword>
	<keyword>continuous positive airway pressure therapy</keyword>
	<keyword>sham treatment</keyword>
	<keyword>randomize clinical trial</keyword>
	<keyword>behavior</keyword>
	<keyword>treatment</keyword>
</DOC>